Susan Trent

Susan Trent has extensive experience in leadership roles within the healthcare and consumer goods sectors. As Chief Executive Officer of INNOVO by Atlantic Therapeutics from November 2019 to November 2023, Susan oversaw strategic initiatives and growth. Prior to this, Susan served as a Strategic Business Consultant at Valensa International, assisting in the launch of a health supplement. At GlaxoSmithKline, Susan held various senior positions, including V.P. and Global Business Lead for Skin Health, contributing to brand innovation and commercial success, and V.P., Strategy for Consumer Healthcare North America, where Susan led a significant divestment while ensuring business momentum. With a strong background in marketing and business development across international markets, Susan holds a BA (Hons) in Russian Studies from The University of Manchester and a CIM Diploma in Marketing from London Metropolitan University.